200 related articles for article (PubMed ID: 38746870)
1. Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.
Chung DC; Ghaedi M; Warner K; Sayad A; Saibil SD; Bernardini MQ; Clarke BA; Shaw PA; Butler MO; Easson A; Morrissy S; Wang BX; Nguyen L; Ohashi PS; Jacquelot N
Oncoimmunology; 2024; 13(1):2349347. PubMed ID: 38746870
[TBL] [Abstract][Full Text] [Related]
2. Isolation and Characterization of Innate Lymphoid Cells within the Murine Tumor Microenvironment.
Mallett G; Patterson W; Payne M; Amarnath S
Methods Mol Biol; 2020; 2121():153-164. PubMed ID: 32147794
[TBL] [Abstract][Full Text] [Related]
3. Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor.
Tumino N; Martini S; Munari E; Scordamaglia F; Besi F; Mariotti FR; Bogina G; Mingari MC; Vacca P; Moretta L
Int J Cancer; 2019 Sep; 145(6):1660-1668. PubMed ID: 30856277
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
[TBL] [Abstract][Full Text] [Related]
5. A distinct innate lymphoid cell population regulates tumor-associated T cells.
Crome SQ; Nguyen LT; Lopez-Verges S; Yang SY; Martin B; Yam JY; Johnson DJ; Nie J; Pniak M; Yen PH; Milea A; Sowamber R; Katz SR; Bernardini MQ; Clarke BA; Shaw PA; Lang PA; Berman HK; Pugh TJ; Lanier LL; Ohashi PS
Nat Med; 2017 Mar; 23(3):368-375. PubMed ID: 28165478
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA-seq identifies a PD-1
Yu Y; Tsang JC; Wang C; Clare S; Wang J; Chen X; Brandt C; Kane L; Campos LS; Lu L; Belz GT; McKenzie AN; Teichmann SA; Dougan G; Liu P
Nature; 2016 Nov; 539(7627):102-106. PubMed ID: 27749818
[TBL] [Abstract][Full Text] [Related]
7. Activated innate lymphoid cell populations accumulate in human tumour tissues.
Salimi M; Wang R; Yao X; Li X; Wang X; Hu Y; Chang X; Fan P; Dong T; Ogg G
BMC Cancer; 2018 Mar; 18(1):341. PubMed ID: 29587679
[TBL] [Abstract][Full Text] [Related]
8. Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.
Nixon BG; Li MO
J Immunol; 2018 Jan; 200(2):408-414. PubMed ID: 29311382
[TBL] [Abstract][Full Text] [Related]
9. NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.
Luci C; Bekri S; Bihl F; Pini J; Bourdely P; Nouhen K; Malgogne A; Walzer T; Braud VM; Anjuère F
PLoS One; 2015; 10(12):e0143224. PubMed ID: 26630176
[TBL] [Abstract][Full Text] [Related]
10. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
Front Immunol; 2019; 10():910. PubMed ID: 31105707
[TBL] [Abstract][Full Text] [Related]
11. Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.
Xu Y; Chen L; Xu B; Xiong Y; Yang M; Rui X; Shi L; Wu C; Jiang J; Lu B
Cell Physiol Biochem; 2017; 41(2):475-483. PubMed ID: 28214872
[TBL] [Abstract][Full Text] [Related]
12. Innate lymphoid cells and cancer: Role in tumor progression and inhibition.
Yuan X; Rasul F; Nashan B; Sun C
Eur J Immunol; 2021 Sep; 51(9):2188-2205. PubMed ID: 34189723
[TBL] [Abstract][Full Text] [Related]
13. The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment.
Ducimetière L; Vermeer M; Tugues S
Front Immunol; 2019; 10():2895. PubMed ID: 31921156
[TBL] [Abstract][Full Text] [Related]
14. Innate lymphoid cells and cancer at border surfaces with the environment.
Mattiola I; Diefenbach A
Semin Immunol; 2019 Feb; 41():101278. PubMed ID: 31473072
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal immune system in patients with advance epithelial ovarian cancer.
Wertel I; Nowicka A; Rogala E; Kotarski J
Int Rev Immunol; 2011; 30(2-3):87-101. PubMed ID: 21557636
[TBL] [Abstract][Full Text] [Related]
17. The role of ILC subsets in cancer.
Bruchard M; Spits H
Semin Immunol; 2022 Nov; 61-64():101654. PubMed ID: 36306660
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Matsuzaki J; Gnjatic S; Mhawech-Fauceglia P; Beck A; Miller A; Tsuji T; Eppolito C; Qian F; Lele S; Shrikant P; Old LJ; Odunsi K
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7875-80. PubMed ID: 20385810
[TBL] [Abstract][Full Text] [Related]
19. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
20. Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?
Tumino N; Vacca P; Quatrini L; Munari E; Moretta F; Pelosi A; Mariotti FR; Moretta L
Front Immunol; 2019; 10():3140. PubMed ID: 32063901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]